selected publications
-
PD-1 Blockade in Chinese versus Western Patients with Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Comment
GET IT
Times cited: 20 -
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 35 -
Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Academic Article
GET IT
Times cited: 165 -
About Face: Molecular Aberrations in Head and Neck Mucosal Melanomas.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2019
Comment
GET IT
Times cited: 7 -
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy.
Cancer.
2018
Academic Article
GET IT
Times cited: 46 -
Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma.
The British journal of ophthalmology.
2018
Academic Article
GET IT
Times cited: 10 -
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor.
Investigational new drugs.
2018
Academic Article
GET IT
Times cited: 36 -
GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma.
Cell reports.
2018
Academic Article
GET IT
Times cited: 64 -
Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.
Cancer medicine.
2018
Academic Article
GET IT
Times cited: 105 -
Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma.
JAMA oncology.
2018
Academic Article
GET IT
Times cited: 141 -
Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy.
Ophthalmology.
2017
Academic Article
GET IT
Times cited: 119 - An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses. 2017 GET IT
-
Patient perspectives on ipilimumab across the melanoma treatment trajectory.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
2017
Academic Article
GET IT
Times cited: 23 -
Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma.
Melanoma research.
2017
Academic Article
GET IT
Times cited: 44 -
Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab.
Journal of the National Cancer Institute.
2016
Academic Article
GET IT
Times cited: 62 -
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 116 -
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2016
Academic Article
GET IT
Times cited: 503 -
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.
Cancer.
2016
Academic Article
GET IT
Times cited: 311 -
The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
Cancer.
2016
Academic Article
GET IT
Times cited: 261 -
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
The oncologist.
2016
Academic Article
GET IT
Times cited: 164 -
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma.
Melanoma research.
2016
Academic Article
GET IT
Times cited: 34 -
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma.
Sarcoma.
2016
Academic Article
GET IT
Times cited: 10 -
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma.
Nature genetics.
2016
Academic Article
GET IT
Times cited: 247 -
Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.
Head & neck.
2016
Academic Article
GET IT
Times cited: 79 -
Treatment of Uveal Melanoma.
Cancer treatment and research.
2016
Review
GET IT
Times cited: 18 -
Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation.
Journal for immunotherapy of cancer.
2015
Academic Article
GET IT
Times cited: 95 -
GNAQ and GNA11 mutations in uveal melanoma.
Melanoma research.
2014
Review
GET IT
Times cited: 105 -
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment.
Human pathology.
2014
Academic Article
GET IT
Times cited: 255 - A woman with metastatic pancreatic neuroendocrine tumor. Gastrointestinal cancer research : GCR. 2014 Academic Article GET IT
-
Novel treatment targets in sarcoma: more than just the GIST.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
2014
Review
GET IT
Times cited: 7 -
Metastasis-suppressor genes in clinical practice: lost in translation?.
Nature reviews. Clinical oncology.
2011
Review
GET IT
Times cited: 47 -
Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
Cancer research.
2009
Academic Article
GET IT
Times cited: 170 -
Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling.
Breast disease.
2007
Review
GET IT
Times cited: 14